Literature DB >> 7683483

Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67.

D Bordessoule1, M Jones, K C Gatter, D Y Mason.   

Abstract

A number of differentiation antigens on myeloid cells have been defined on the CD classification system by the four International Workshops on Human Leucocyte Differentiation Antigens. The distribution of eight of these antigens (CD13, CD14, CD16, CD31, CD36, CD65, CD66, CD67) have been studied in human tissues, with the aim of documenting their immunohistological patterns and their degree of myeloid restriction. CD13, the most widely distributed antigen, was found in skin, bile canaliculi, kidney and pancreas. CD14 was not restricted to monocytes and tissue macrophages, being also strongly expressed on dendritic reticulum cells. CD16 was expressed on granulocytes and tissue macrophages (alveolar and Kupffer cells) and in the red pulp of the spleen. CD31 and CD36 gave a characteristic staining of vascular endothelium, corresponding to their identification as the platelet glycoproteins gp IIa and gp IV. Antibodies against the most recently defined myeloid antigens (CD65, CD66 and CD67) appeared to be more specific for myeloid differentiation than previously described 'myeloid antigens'.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683483     DOI: 10.1111/j.1365-2141.1993.tb04659.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  Cell Surface CD36 Protein in Monocyte/Macrophage Contributes to Phagocytosis during the Resolution Phase of Ischemic Stroke in Mice.

Authors:  Moon-Sook Woo; Jiwon Yang; Cesar Beltran; Sunghee Cho
Journal:  J Biol Chem       Date:  2016-09-19       Impact factor: 5.157

Review 2.  Functional roles of cell surface peptidases in reproductive organs.

Authors:  Hiroshi Fujiwara
Journal:  Reprod Med Biol       Date:  2004-12-03

3.  CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia.

Authors:  Eunhee Kim; Maria Febbraio; Yi Bao; Aaron T Tolhurst; Jeffrey M Epstein; Sunghee Cho
Journal:  Ann Neurol       Date:  2012-06       Impact factor: 10.422

4.  A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy.

Authors:  Inga Buchmann; Thomas Kull; Gerhard Glatting; Donald Bunjes; Geoffrey Hale; Jorg Kotzerke; Dirk Rattat; Hartmut Dohner; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-22       Impact factor: 9.236

5.  Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironments.

Authors:  A Bhatia; S Blades; G Cambridge; J C Edwards
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

6.  Receptor-dependent coronavirus infection of dendritic cells.

Authors:  Brian C Turner; Erin M Hemmila; Nicole Beauchemin; Kathryn V Holmes
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Application of knockout mouse models to investigate the influence of FcγR on the pharmacokinetics and anti-platelet effects of MWReg30, a monoclonal anti-GPIIb antibody.

Authors:  Lubna Abuqayyas; Xiaoyan Zhang; Joseph P Balthasar
Journal:  Int J Pharm       Date:  2013-01-28       Impact factor: 5.875

8.  Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.

Authors:  Eun-Hee Kim; Aaron T Tolhurst; Hazel H Szeto; Sung-Hee Cho
Journal:  CNS Neurosci Ther       Date:  2014-09-12       Impact factor: 5.243

9.  Fusobacterium spp. target human CEACAM1 via the trimeric autotransporter adhesin CbpF.

Authors:  Matthew L Brewer; David Dymock; R Leo Brady; Bernhard B Singer; Mumtaz Virji; Darryl J Hill
Journal:  J Oral Microbiol       Date:  2019-01-24       Impact factor: 5.474

10.  Angiogenesis in male breast cancer.

Authors:  Evan M Frangou; Joshua Lawson; Rani Kanthan
Journal:  World J Surg Oncol       Date:  2005-03-02       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.